Literature DB >> 16622116

Intraperitoneal therapy for advanced ovarian cancer: will it become standard care?

Charles Bankhead.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16622116     DOI： 10.1093/jnci/djj173

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis.

Authors:  Olivier Facy; François Radais; Sylvain Ladoire; Delphine Delroeux; Hervé Tixier; François Ghiringhelli; Patrick Rat; Bruno Chauffert; Pablo Ortega-Deballon
Journal:  J Exp Clin Cancer Res       Date:  2011-01-07

2.  Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.

Authors:  Edmond Auzenne; Sukhen C Ghosh; Mojgan Khodadadian; Belinda Rivera; David Farquhar; Roger E Price; Murali Ravoori; Vikas Kundra; Ralph S Freedman; Jim Klostergaard
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

3.  Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan.

Authors:  Sergio Cafaggi; Eleonora Russo; Rossana Stefani; Brunella Parodi; Gabriele Caviglioli; Greta Sillo; Angela Bisio; Cinzia Aiello; Maurizio Viale
Journal:  Invest New Drugs       Date:  2009-12-29       Impact factor: 3.850
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.